Testing an inotrope medicine versus placebo in shock patients
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies whether an inotrope medicine (a drug that helps the heart pump) works better than a placebo in adults in intensive care with cardiogenic shock. It may help doctors find safer, more effective treatment for this life-threatening condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently in the intensive care unit
- Your doctors have told you you have cardiogenic shock in SCAI class C or D
- You (or your substitute decision-maker) can agree to the study consent
- You are not pregnant and not breast-feeding
- You have not had milrinone or dobutamine in the last 24 hours before randomization
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study looks at how well the heart is pumping in people with cardiogenic shock, using measurements taken during a right-heart catheter (a small pressure-monitoring test). It may help doctors better assess heart function and guide next-step treatments like LVAD, heart transplant, or valve surgery.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This trial compares two medicines (norepinephrine and dopamine) used to help the heart pump blood when it has severely weakened. You may qualify if your heart is not pumping well enough and you need medication support to maintain blood pressure.
This trial studies whether doctors can safely reduce heart and blood-pressure support sooner in people with severe heart failure “shock.” It may help avoid side effects of strong medicines/devices while keeping the body’s organs well supported.
This trial is testing different approaches (medications and mechanical support) to help people with acute heart failure and cardiogenic shock (a sudden drop in the heart's pumping ability). It looks at how well these treatments work in a network of hospitals to improve outcomes.
Hear when a new Shock, Cardiogenic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.